Atlas Trials

Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis

Clinical trial NCT00237159 · COMPLETED

Trial details

NCT number
NCT00237159
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Prostate Cancer Patients With Bone Metastasis
Start date
2002-10-01
Primary completion
2005-12-01
Enrollment
284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.